For and against: Direct to consumer advertising is medicalising normal human experience: For
- PMID: 11950745
- PMCID: PMC1122842
- DOI: 10.1136/bmj.324.7342.908
For and against: Direct to consumer advertising is medicalising normal human experience: For
Comment in
-
For and against: Direct to consumer advertising is medicalising normal human experience: Against.BMJ. 2002 Apr 13;324(7342):910-1. doi: 10.1136/bmj.324.7342.910. BMJ. 2002. PMID: 11950746 Free PMC article. No abstract available.
References
-
- Kawachi I, Conrad P. Medicalization and the pharmacological treatment of blood pressure. In: Davis P, editor. Contested ground. Public purpose and private interests in the regulation of prescription drugs. New York: Oxford University Press; 1996.
-
- IMS Health. IMS Health reports pharmaceutical direct-to-consumer advertising investment in US reaches $1.3 billion in first-half 2000. www.imshealth.com (accessed 20 Jan 2002).
-
- Researched Medicines Industry Association of New Zealand. DTC advertising can enhance public health. The case for for direct-to-consumer prescription medicine advertising. (Briefing paper, June 2000.) www.rmianz.co.nz/briefing%20papers/dtc.htm (accessed 27 Mar 2002).
-
- Thomas L. The medusa and the snail. New York: Bantam Books; 1980.
-
- Green CJ, Bassett K, Foerster V, Kazanjian A. Bone mineral density testing: does the evidence support its selective use in well women? Vancouver, BC: British Columbia Office of Health Technology Assessment; 1997. www.chspr.ubc.ca//bcohta/pdf/bmd.pdf . (BCOHTA 97:2T.) www.chspr.ubc.ca//bcohta/pdf/bmd.pdf (accessed 10 Feb 2002). (accessed 10 Feb 2002).
MeSH terms
LinkOut - more resources
Full Text Sources